Copyright
©The Author(s) 2021.
World J Stem Cells. Jan 26, 2021; 13(1): 49-63
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.49
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.49
Characteristic | Exosomes | Microvesicles | Apoptotic bodies |
Size (nm) | 20-100 | 50-1000 | 500-2000 |
Morphology | Cup/round shaped | Various shapes | Heterogeneous |
Sucrose gradient | 1.13–1.19 g/mL | 1.04–1.07 g/mL | 1.16–1.28 g/mL |
Biogenesis | Endosomes | Plasma membrane | Plasma membrane, endoplasmic reticulum |
Contents | Nucleic acids, cytoplasmic and membrane protein, major histocompatibility complex, lipid | Nucleic acids, cytoplasmic and membrane protein, receptor proteins, lipid | Nuclear fractions, DNA, cell organelles |
Biomarkers | Tetraspanins family, actin, flotillin, Hsc70, Hsp 90, Hsp60 and Hsp20, clathrin, integrins | Integrins, selectins, flotillin-2, CD40, ligand, metalloproteinase | Annexin V positivity, phosphatidyl serine |
- Citation: Shi J, Zhao YC, Niu ZF, Fan HJ, Hou SK, Guo XQ, Sang L, Lv Q. Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect. World J Stem Cells 2021; 13(1): 49-63
- URL: https://www.wjgnet.com/1948-0210/full/v13/i1/49.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i1.49